ETF Holdings Breakdown of WVE

WVE institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	88,403	USD 601,140
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	53,633	USD 364,704
2025-09-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	88,574	USD 602,303
2025-09-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	88,574	USD 602,303
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	866	USD 5,889 2.1%
Total =		320,050	USD 2,176,339

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with WVE

WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Average Rating of “Moderate Buy” from Analysts

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year […] - 2025-09-19 03:14:54

Brokerages Set WAVE Life Sciences Ltd. (NASDAQ:WVE) PT at $20.27

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the fifteen analysts that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12-month target price […] - 2025-08-28 03:14:50

WVE Crosses Above Key Moving Average Level

In trading on Monday, shares of Wave Life Sciences Ltd (Symbol: WVE) crossed above their 200 day moving average of $9.87, changing hands as high as $9.93 per share. Wave Life Sciences Ltd shares are currently trading up about 0.1% on the day. The chart below shows the one year - 2025-08-18 12:40:20

Chicago Partners Investment Group LLC Invests $103,000 in WAVE Life Sciences Ltd. (NASDAQ:WVE)

Chicago Partners Investment Group LLC purchased a new position in WAVE Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 12,708 shares of the company’s stock, valued at approximately $103,000. A number of other institutional investors also recently made changes […] - 2025-08-13 05:42:58

XTX Topco Ltd Makes New Investment in WAVE Life Sciences Ltd. (NASDAQ:WVE)

XTX Topco Ltd acquired a new position in WAVE Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 27,792 shares of the company’s stock, valued at approximately $225,000. A number of other hedge funds have also recently made changes to their positions in the business. Bank of New […] - 2025-08-13 04:26:46

WAVE Life Sciences (NASDAQ:WVE) Now Covered by Analysts at Canaccord Genuity Group

Canaccord Genuity Group initiated coverage on shares of WAVE Life Sciences (NASDAQ:WVE – Free Report) in a research note released on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $19.00 price objective on the stock. Several other research firms have also weighed in on WVE. Wedbush reiterated an “outperform” rating and […] - 2025-08-05 05:36:48

Wave (WVE) Q2 Revenue Drops 56%

Key PointsRevenue declined sharply to $8.7 million in Q2 fiscal year 2025, missing analyst expectations by 34.1% and falling 55.8% compared to the prior year period. - 2025-07-31 04:10:48

WAVE Life Sciences (NASDAQ:WVE) Coverage Initiated by Analysts at Citigroup

Equities research analysts at Citigroup started coverage on shares of WAVE Life Sciences (NASDAQ:WVE – Get Free Report) in a report released on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $16.00 price target on the stock. Citigroup’s price target would indicate a potential upside of 99.75% from the company’s previous close. […] - 2025-07-18 05:05:15

WAVE Life Sciences (NASDAQ:WVE) Earns Outperform Rating from Wedbush

WAVE Life Sciences (NASDAQ:WVE – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a note issued to investors on Monday,Benzinga reports. They presently have a $18.00 target price on the stock. Wedbush’s target price suggests a potential upside of 163.54% from the company’s previous close. Other research analysts […] - 2025-06-25 02:50:54

Wave Life Sciences (NASDAQ:WVE) Now Covered by Raymond James

Raymond James assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The firm issued an outperform rating and a $14.00 target price on the stock. Several other equities research analysts have also issued reports on the stock. Jefferies Financial […] - 2025-06-12 04:56:56

Squarepoint Ops LLC Invests $256,000 in Wave Life Sciences Ltd. (NASDAQ:WVE)

Squarepoint Ops LLC purchased a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 20,659 shares of the company’s stock, valued at approximately $256,000. Several other institutional investors have […] - 2025-06-08 06:38:59

Two Sigma Advisers LP Buys Shares of 68,100 Wave Life Sciences Ltd. (NASDAQ:WVE)

Two Sigma Advisers LP bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 68,100 shares of the company’s stock, valued at approximately $842,000. Other institutional investors and hedge […] - 2025-06-03 04:57:00

Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 362,291 Wave Life Sciences Ltd. (NASDAQ:WVE)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 362,291 shares of the company’s stock, valued at approximately $4,482,000. Universal Beteiligungs und Servicegesellschaft […] - 2025-06-02 05:57:07

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC reduced its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 24.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 33,184 shares of the company’s stock after selling 10,820 shares during the period. ProShare […] - 2025-05-28 07:00:45

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Two Sigma Investments LP

Two Sigma Investments LP grew its stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 210.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 391,620 shares of the company’s stock after buying an additional 265,437 shares during the […] - 2025-05-28 05:04:55

Hsbc Holdings PLC Sells 3,565 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)

Hsbc Holdings PLC lessened its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 25.0% during the 4th quarter, Holdings Channel reports. The firm owned 10,721 shares of the company’s stock after selling 3,565 shares during the period. Hsbc Holdings PLC’s holdings in Wave Life Sciences were worth $132,000 at the […] - 2025-05-12 04:56:50

Voya Investment Management LLC Acquires 51,281 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)

Voya Investment Management LLC increased its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 198.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 77,160 shares of the company’s stock after buying an additional 51,281 shares during the period. Voya Investment Management LLC’s holdings in Wave Life Sciences were […] - 2025-05-07 05:57:01

MetLife Investment Management LLC Buys 12,340 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)

MetLife Investment Management LLC increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,941 shares of the company’s stock after buying an additional 12,340 shares […] - 2025-05-05 05:22:48

Barclays PLC Has $2.42 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)

Barclays PLC increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 22.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 195,553 shares of the company’s stock after buying an additional 36,312 shares during the quarter. Barclays PLC’s holdings in Wave Life Sciences were worth $2,418,000 at the […] - 2025-05-01 05:12:58

Wave Life Sciences (NASDAQ:WVE) Earns Overweight Rating from Analysts at Cantor Fitzgerald

Research analysts at Cantor Fitzgerald initiated coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $10.00 price target on the stock. Cantor Fitzgerald’s price objective suggests a potential upside of 29.53% from the company’s […] - 2025-05-01 03:02:55

Russell Investments Group Ltd. Boosts Position in Wave Life Sciences Ltd. (NASDAQ:WVE)

Russell Investments Group Ltd. increased its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 3,471.8% in the 4th quarter, HoldingsChannel reports. The fund owned 44,648 shares of the company’s stock after purchasing an additional 43,398 shares during the quarter. Russell Investments Group Ltd.’s holdings in Wave Life Sciences were worth $552,000 at […] - 2025-04-24 04:44:47

Wave Life Sciences (NASDAQ:WVE) Now Covered by Analysts at Wedbush

Analysts at Wedbush assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm set an “outperform” rating and a $18.00 price target on the stock. Wedbush’s price objective would suggest a potential upside of 193.16% from the stock’s previous […] - 2025-04-10 04:13:09

Teacher Retirement System of Texas Grows Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)

Teacher Retirement System of Texas boosted its position in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 57.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,473 shares of the company’s stock after acquiring an additional 11,507 shares during the quarter. Teacher Retirement System of Texas’ holdings in Wave Life Sciences were […] - 2025-04-01 04:44:43

Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) have been given a consensus rating of “Buy” by the ten analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy […] - 2025-03-28 04:08:55

Wave Life Sciences (NASDAQ:WVE) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) Financial Comparison

Wave Life Sciences (NASDAQ:WVE – Get Free Report) and Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of […] - 2025-03-12 04:11:02

Wave Life Sciences (NASDAQ:WVE) Stock Rating Upgraded by StockNews.com

Wave Life Sciences (NASDAQ:WVE – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities research analysts also recently issued reports on WVE. Jefferies Financial Group began coverage on shares of Wave Life Sciences in a research […] - 2025-03-10 04:20:52

Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.60 Consensus PT from Brokerages

Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) have been given an average rating of “Buy” by the ten brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating […] - 2025-03-06 04:45:53

Rhumbline Advisers Has $1.54 Million Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)

Rhumbline Advisers increased its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 16.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,840 shares of the company’s stock after purchasing an additional 17,316 shares during the quarter. Rhumbline […] - 2025-03-05 08:18:53

Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Jefferies Financial Group

Research analysts at Jefferies Financial Group began coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $26.00 price target on the stock. Jefferies Financial Group’s target price would suggest a potential upside […] - 2025-02-27 06:44:56

Back to Listing

Disclaimer